CHIARAMONTE, ELOISA
CHIARAMONTE, ELOISA
Universita' degli Studi di MILANO
ALTERAZIONI ISTOPATOLOGICHE INDOTTE DA CELLULE UMANE LAM/TSC IN TOPI NUDI: UN MODELLO DI LINFANGIOLEIOMIOMATOSI. REVERSIONE DEL DANNO CON ANTICORPO ANTI-EGFR
2012-02-27 E. Chiaramonte
Anti-EGFR antibody reduces lung nodules by inhibition of EGFR-pathway in a model of lymphangioleiomyomatosis
2015-01-01 E. Lesma, E. Chiaramonte, S. Ancona, E. Orpianesi, A.M. Di Giulio, A. Gorio
Characterization of LAM/TSC cells isolated from patient chylous
2010-04-13 E. Lesma, S. Ancona, V. Grande, S.M. Sirchia, E. Chiaramonte, S. Bosari, A.M. Di Giulio, A. Gorio
Development of a LAM model by using human TSC2 deficient smooth muscle cells derived from a renal angiomylipoma
2010-04-12 E. Lesma, E. Chiaramonte, V. Grande, S. Ancona, A.M. Di Giulio, A. Gorio
Development of a lymphangioleiomyomatosis model by endonasal administration of human TSC2-/- smooth muscle cells in mice
2012-09-01 E. Lesma, E. Chiaramonte, E. Isaia, V. Grande, S. Ancona, E. Orpianesi, A.M. Di Giulio, A. Gorio
Differential modulation of matrix metalloproteinases-2 and-7 in LAM/TSC cells
2021-11-24 S. Ancona, E. Orpianesi, C. Bernardelli, E. Chiaramonte, R. Chiaramonte, S. Terraneo, F. Di Marco, E. Lesma
An epigenetic event may underlies the TSC features in TSC2 ASM cells
2009-09-01 E. Lesma, S. Ancona, S.M. Sirchia, V. Grande, E. Chiaramonte, S. Bosari, A.M. Di Giulio, A. Gorio
Human smooth muscle TSC2-/- cells cause lymphangiogenesis-like lung destruction in nude mice. Pharmacological repair
2009-01-01 E. Lesma, E. Chiaramonte, S. Ancona, V. Grande, R. Adami, A.M. Di Giulio, A. Gorio
LAM/TSC cell migration to uterus in an experimental model of lymphangioleiomyomatosis. Regulation by anti-epidermal growth factor receptor antibody and rapamycin
2014-01-01 E. Lesma, E. Chiaramonte, S. Ancona, A.M. Di Giulio, A. Gorio
Un modello di linfangioleiomiomatosi con la somministrazione di cellule muscolari lisce umane TSC2-/-
2010-10-22 E. Lesma, E. Chiaramonte, V. Grande, S. Ancona, F. La Briola, M.P. Canevini, M. Corona, F. Ghelma, A.M. Di Giulio, A. Gorio
A mouse LAM model by endonasal administration of human TSC2 deficient smooth muscle cells
2010-05-01 E. Lesma, E. Chiaramonte, S. Ancona, V. Grande, A.M. Di Giulio, A. Gorio
Pathogenesis and pharmacological evaluation of human TSC2 smooth muscle cells. Possible treatment options for TSC and lymphangioleiomyomatosis
2009-01-01 E. Lesma, V. Grande, S. Ancona, E. Chiaramonte, S.M. Sirchia, A.M. Di Giulio, A. Gorio
Promoter methylation of TSC2 gene is important for pathogenesis of TSC and LAM lesions
2009-01-01 S. Ancona, E. Lesma, S.M. Sirchia, V. Grande, E. Chiaramonte, A.M. Di Giulio, A. Gorio
Role of HMG-CoA reductase inhibitors in controlling TSC2-/- ASM cell growth and proliferation
2009-01-01 V. Grande, E. Lesma, S. Ancona, E. Chiaramonte, A.M. Di Giulio, A. Gorio
TSC2 epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival
2014-03-01 E. Lesma, S. Ancona, S.M. Sirchia, E. Orpianesi, V. Grande, P. Colapietro, E. Chiaramonte, A.M. Di Giulio, A. Gorio